Adolescent vaccination rates for protection against diseases including pertussis, meningococcal disease, and human papillomavirus (HPV)–associated cancers were discussed in the CDC's Morbidity and Mortality Weekly Report (MMWR) released July 31, 2015 "National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014". 64(29);784-792
CDC. Pertussis and Influenza Vaccination among Insured Pregnant Women, Wisconsin, 2013–2014, July 17, 2015 64(27);746-750
> This MMWR reports that "The percentage of women who received Tdap during pregnancy increased from 13.8% of women delivering during January 2013 (63.1% of whom received Tdap 2–13 weeks before delivery) to 51.0% of women delivering during March 2014 (90.9% of whom received Tdap 2–13 weeks before delivery). Among women delivering during November 2013–March 2014, 49.4% had received influenza vaccine during pregnancy."
CDC Tetanus, Diphtheria, Pertussis Vaccination Coverage Before, During, and After Pregnancy — 16 States and New York City, 2011. MMWR May 22, 2015:64(19);522-526
CDC Pertussis Epidemic- California 2014. MMWR. Dec. 5, 2014. 63 (48);1129-1132.
CDC Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012. MMWR. Feb. 22, 2013. 620 (07);131-135.
Tetanus, diphtheria, and acellular pertussis vaccination among women of childbearing age-United States, 2013. O'Halloran AC, Lu PJ, Williams WW, Ding H, Meyer SA.Am J Infect Control. 2016 Jul 1;44(7):786-93. doi: 10.1016/j.ajic.2016.03.048.
Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid,and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011-2015. Moro PL, Cragan J, Tepper N, Zheteyeva Y, Museru O, Lewis P, Broder K. Vaccine. 2016 Apr 29;34(20):2349-53. doi: 10.1016/j.vaccine.2016.03.049. Epub 2016 Mar 22.
Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study. Walls T, Graham P, Petousis-Harris H, Hill L, Austin N. BMJ Open. 2016 Jan 6;6(1):e009536. doi: 10.1136/bmjopen-2015-009536.
Morgan, J; Baggari, S; Chung, W; Ritch, J; McIntire, D; Sheffield, J. Association of a Best-Practice Alert and Prenatal Administration With Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination Rates. Obstetrics & Gynecology. August 2015. 126(2); 333–337.
>This article concludes that the use of a best-practice alert, in concert with the recommended change in timing of maternal vaccination from postpartum to antepartum, was associated with an increase in the Tdap immunization rate to 97%
Sukumaran L, McCarthy N, Kharbanda E, McNiel M, Naleway A, Klein N, et al. Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations. JAMA. October 20, 2015. 314 (15): 1581-1587.
Sukumaran L, McCarthy N, Kharbanda E, Weintraub E, Vazquez-Benitez G, McNeil, M. et al. Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy. Obstetrics & Gynecology. published online ahead-of-print October 5, 2015.
Cherry JD. Editorial Commentary: Tetanus-Diphtheria-Pertussis Immunization in Pregnant Women and the Prevention of Pertussis in Young Infants, Clinical Infectious Diseases (2015) 60(3):338-340.
Dabrera, G., Amirthalingam, G., et.el. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013Journal Clinical Infectious Disseases 60 (3)(2015):333-337
Leibson T, St-Onge M, Koren G. TDM Journal Club: Safety and Immunogenicity of Tetanus Diphteria and Acellular Pertussis Immunization During Pregnancy, Therapeutic Drug Monitoring (2015) 37(3):283-4.
Abu Raya B, Srugo I, Kessel A, et al. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels, A prospective study, Vaccine (2014) 32(44):5787-93.
Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study, The Lancet (2014) 384(9953):1521-8.
Goldfarb IT, Little S, Brown J, Riley LE. Use of the combined tetanus-diphtheria and pertussis vaccine during pregnancy,Am J Obstet Gynecol (2014) 211(3):299.e1-.e5.
Hardy-Fairbanks AJ. Immune responses in infants whose mothers received Tdap vaccine during pregnancy,The Pediatric infectious disease journal (2013) 32(11):1257-60.
Harriman K, Winter K. Pertussis vaccine uptake during pregnancy: We need to do better in the U.S., Preventive Medicine (2014) 67:320-1.
Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clinical Infectious Diseases, Clin Infect Dis (2013) 56(4):539-44.
Kharbanda EO, Vazquez-Benitez G, et al. Receipt of Pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink Sites, Prev Med. (2014) 67:316-9.
Kharbanda E, Vasquez-Benitez G, et. al. Evaluation of the Association of Maternal Pertussis Vaccination with Obstetric Events and Birth Outcomes. JAMA. (2014) 312(18):1897-1904.
Munoz FM, Bond NH, Maccato M, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (tdap) immunization during pregnancy in mothers and infants: A randomized clinical trial, JAMA (2014) 311(17):1760-9.
Rasmussen SA, Watson AK, Kennedy ED, Broder KR, Jamieson DJ. Vaccines and pregnancy: Past, present, and future. Seminars in Fetal and Neonatal Medicine, Semin Fetal Neonatal Med (2014)19(3):161-9.
Rosenblum E, McBane S, et.al. Protecting newborns by immunizing family members in a hospital-based vaccine clinic: a successful Tdap cocooning program during the 2010 California pertussis epidemic, Public Health Reports (2014) 129(3):245-51.
Tanriover MD, Soyler C, Ascioglu S, Cankurtaran M, Unal S. Low seroprevalance of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination, Eur J Intern Med (2014) 25(6):528-32.
Terranella, A., Asay, G., et.al. Pregnancy Dose Tdap and Postpartum Cocooning to Prevent Infant Pertussis: A Decision Analysis,Pediatrics (2013) doi: 10.1542/peds.2012-3144. The article concluded that Tdap vaccination during pregnancy could avert more infant cases and deaths at lower cost than postpartum vaccination.